Delivery Order SPE2DR25D3103-SPE2DR26F0C1P
Award Date 2/10/26
Potential Completion Date 2/11/26
Potential Value $1.2K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency issued a $2,382.60 delivery order to Amerisourcebergen Drug Corp on February 12, 2026, for Risperdal 3 mg tablets (60-count supply). Place of performance is Conshohocken, PA. The order has a firm fixed price and an ultimate completion date of February 13, 2026. The delivery order was issued under the parent company Cencora, Inc.'s Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031, which supplies...
- The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 17, 2026, for Risperdal 0.5 mg tablets (60-count), with a ceiling value of $2,188.80. Place of performance is Conshohocken, PA. The ultimate completion date is February 18, 2026. This firm fixed-price delivery order was issued without a set-aside under a parent Indefinite Delivery Contract with the DLA Troop Support Medical that supports pharmaceutical supply to military healthcare programs globally.
- <p>The Defense Logistics Agency issued a $1,824.00 delivery order to Amerisourcebergen Drug Corp on February 11, 2026, for Risperdal 0.5 mg tablets (60-count).</p> <p>Place of performance is Conshohocken, PA. The order is firm fixed price with an ultimate completion date of February 12, 2026. No set-aside was used.</p>
- The Defense Logistics Agency awarded a delivery order valued at $4,361.07 to AmerisourceBergen Drug Corp for the supply of Risperdal 0.5 mg tablets (60 count) on January 8, 2026, with a completion date of January 9, 2026. This firm fixed-price, competitively awarded delivery order was issued from Conshohocken, Pennsylvania, where the vendor maintains its corporate office. The award carries no set-aside designation, indicating it was competed on a full and open basis. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 18, 2025, for the supply of Risperdal 2 mg tablets in quantities of 60 units, with a ceiling value of $5,442.02. This is a firm fixed price delivery order with no set-aside designation, indicating the award was competitively procured. The contract is scheduled for ultimate completion on December 19, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- <p>The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 2, 2026, for Risperdal 1 mg tablet UD 100s, with a ceiling value of $1,532.96, under firm fixed-price pricing.</p> <p>Place of performance is Conshohocken, PA. The order is due for completion by February 3, 2026. No set-aside was used.</p>
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Risperdal 0.5 mg tablets (60-count) on January 13, 2026, with a ceiling value of $1,746.55 and ultimate completion date of January 14, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the awardee's Conshohocken, Pennsylvania facility. The contract represents a task order under AmerisourceBergen's parent company, Cencora, Inc.'s,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Risperdal 2 mg tablets in quantities of 60 units, with a ceiling value of $2,008.32. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The order is scheduled for ultimate completion by September 16, 2025, and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania location. This delivery order...
- The Defense Logistics Agency awarded a $1,387.02 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Risperdal 2 mg, a pharmaceutical product used in treating psychiatric conditions. This firm fixed-price delivery order, awarded on August 20, 2025, with an ultimate completion date of August 21, 2025, is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract utilizes no set-aside designation, indicating it was competitively awarded...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $2,675.13 firm fixed-price delivery order for 60 tablets of Risperdal 0.5 mg on December 1, 2025, with completion due by December 2, 2025. This is a non-set-aside award to the pharmaceutical distributor's corporate office located in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
- SPE2DR25D3103Indefinite Delivery Contract
- SPE2DR25D3103-SPE2DR26F0C1PDelivery Order
The Defense Logistics Agency issued a $1,195.78 delivery order to Amerisourcebergen Drug Corp on February 10, 2026, for Risperdal 0.5 mg tablets (60-count). Ultimate completion date is February 11, 2026. Place of performance is Conshohocken, PA. The order carries firm fixed pricing and was issued under no set-aside. The source does not identify the parent IDC vehicle name explicitly; the awardee holds a significant IDC with DLA Troop Support Medical valued at up to $999,999,999.00 through December 2026, which likely serves as the parent vehicle for this pharmaceutical supply order.
Generated 5/11/26, 11:55 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 2/9/26 |